Forest Files NDA For Alzheimer's Combination Therapy

Forest Laboratories announced it has submitted an NDA to the FDA for the fixed dose combination of memantine HCL extended release and donepezil HCL as treatment for moderate to severe dementia related to Alzheimer’s disease.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news